Straumann (OTCMKTS:SAUHY) Sees Strong Trading Volume – Here’s What Happened

Shares of Straumann Holding AG (OTCMKTS:SAUHYGet Free Report) saw an uptick in trading volume on Wednesday . 893,521 shares were traded during trading, an increase of 812% from the previous session’s volume of 97,980 shares.The stock last traded at $11.9150 and had previously closed at $11.74.

Analyst Ratings Changes

A number of research analysts recently commented on SAUHY shares. Morgan Stanley reiterated an “underweight” rating on shares of Straumann in a research note on Monday, December 15th. UBS Group raised Straumann from a “sell” rating to a “neutral” rating in a research report on Tuesday, November 4th. Citigroup reiterated a “sell” rating on shares of Straumann in a research note on Wednesday, January 14th. Finally, Deutsche Bank Aktiengesellschaft upgraded Straumann from a “hold” rating to a “buy” rating in a research note on Friday, October 31st. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold”.

Get Our Latest Stock Analysis on SAUHY

Straumann Trading Up 0.9%

The company’s fifty day moving average price is $12.19 and its 200 day moving average price is $11.81.

Straumann Company Profile

(Get Free Report)

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.

Recommended Stories

Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.